Global Cancer Registry Software Market Research Report By Type (Integrated Software, Standalone Software), Deployment Model (Cloud-Based, On-Premise), Database Type (Commercial, Public), Functionality (Patient Care Management, Product Outcome Evaluation, Cancer Reporting to Meet State, Federal Regulations, Medical Research and Clinical Studies), End User (Hospitals, Medical Practices, Government Organizations, Research Centers, Pharmaceutical, Biotechnology, Medical Device Companies and Others) - Forecast till 2024
Market Highlights
The global cancer registry software market held a market value of USD 56.4 million in 2019 and is projected to grow at a CAGR of 10.7% over the forecast period.
Cancer registry software is a disease registry that is mainly used to establish and maintain a cancer incidence reporting system. It acts as an informational resource for the investigation of cancer and its causes. This type of registry software is important as cancer is among the leading causes of death worldwide and therefore the collection of data on cancer cases from diagnosis through survivorship is beneficial to help identify trends and ultimately improve care for patients that are fighting cancer.
Intended Audience
- Software companies
- Contract research organizations
- Academic and research institutes
- Government associations
Avail a Free Sample@ https://www.marketresearchfuture.com/sample_request/7852
Regional Analysis
On a regional basis, the Americas is anticipated to dominate the global cancer registry software market owing to the innovative product development and increasing investment in research and development for innovation in the region.
Europe is expected to hold the second largest position in the global cancer registry software market owing to the presence of strong academic & research base and availability of funding for research in the European countries.
Asia-Pacific is anticipated to be the fastest growing region in the global cancer registry software market owing to the shift of pharmaceutical companies to countries such as India and China, which are low-cost manufacturing regions.
The Middle East & Africa has the least share of the global cancer registry software market. Moreover, the major market share of the region is expected to be held by the Middle East region owing to the growing government initiatives for the healthcare sector.
Segmentation
The global cancer registry software market has been segmented into type, deployment model, database type, functionality and end user.
By type, the market has been segmented into integrated software and standalone software.
Based on deployment model, the market has been segmented into cloud-based models and on-premise models.
On the basis of database type, the market has been segmented into commercial databases and public databases.
By functionality, the market has been segmented into patient care management, product outcome evaluation, cancer reporting to meet state and federal regulations, medical research & clinical studies.
The market, by end user, has been segmented into hospitals & medical practices, government organizations & research centers, pharmaceutical, biotechnology, and medical device companies, and others.
Access Report Details @ https://www.marketresearchfuture.com/reports/cancer-registry-software-market-7852
Key Players
Some of the prominent players in the global cancer registry software market are Onco, Inc., Rocky Mountain Cancer Data Systems, McKesson Corporation, Elekta AB (PUB), C/Net Solutions, Electronic Registry Systems, Inc., Rocky Mountain Cancer Data Systems, McKesson Corporation, Ordinal Data Inc, Conduent Inc, IBM, Himagine Solutions Inc.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: [email protected]
Global Cancer Registry Software Market Research Report By Type (Integrated Software, Standalone Software), Deployment Model (Cloud-Based, On-Premise), Database Type (Commercial, Public), Functionality (Patient Care Management, Product Outcome Evaluation, Cancer Reporting to Meet State, Federal Regulations, Medical Research and Clinical Studies), End User (Hospitals, Medical Practices, Government Organizations, Research Centers, Pharmaceutical, Biotechnology, Medical Device Companies and Others) - Forecast till 2027Market HighlightsThe global cancer registry software market held a market value of USD 56.4 million in 2019 and is projected to grow at a CAGR of 10.7% over the forecast period.
Cancer registry software is a disease registry that is mainly used to establish and maintain a cancer incidence reporting system.
It acts as an informational resource for the investigation of cancer and its causes.
This type of registry software is important as cancer is among the leading causes of death worldwide and therefore the collection of data on cancer cases from diagnosis through survivorship is beneficial to help identify trends and ultimately improve care for patients that are fighting cancer.However, privacy and data security-related concerns and reluctance to adopt advanced solutions may restrict the growth of the market during the forecast period.Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/7852Key PlayersSome of the prominent players in the global cancer registry software market are Onco, Inc., Rocky Mountain Cancer Data Systems, McKesson Corporation, Elekta AB (PUB), C/Net Solutions, Electronic Registry Systems, Inc., Rocky Mountain Cancer Data Systems, McKesson Corporation, Ordinal Data Inc, Conduent Inc, IBM, Himagine Solutions Inc.Regional AnalysisOn a regional basis, the Americas is anticipated to dominate the global cancer registry software market owing to the innovative product development and increasing investment in research and development for innovation in the region.
Europe is expected to hold the second largest position in the global cancer registry software market owing to the presence of strong academic & research base and availability of funding for research in the European countries.Asia-Pacific is anticipated to be the fastest growing region in the global cancer registry software market owing to the shift of pharmaceutical companies to countries such as India and China, which are low-cost manufacturing regions.The Middle East & Africa has the least share of the global cancer registry software market.
Moreover, the major market share of the region is expected to be held by the Middle East region owing to the growing government initiatives for the healthcare sector.SegmentationThe global cancer registry software market has been segmented into type, deployment model, database type, functionality and end user.By type, the market has been segmented into integrated software and standalone software.Based on deployment model, the market has been segmented into cloud-based models and on-premise models.On the basis of database type, the market has been segmented into commercial databases and public databases.By functionality, the market has been segmented into patient care management, product outcome evaluation, cancer reporting to meet state and federal regulations, medical research & clinical studies.The market, by end user, has been segmented into hospitals & medical practices, government organizations & research centers, pharmaceutical, biotechnology, and medical device companies, and others.Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/cancer-registry-software-market-7852About Market Research Future:At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services.
Market Analysis and Insights:- Global Cancer Registry Software MarketGlobal Cancer Registry Software Market By Software (Cross-Disciplinary; Specific); Type (Standalone; Integrated); Deployment Model (On-Premise; Cloud-Based); Database Type (Commercial; Public); Functionality (Cancer Reporting to Meet State & Federal Regulations; Patient Care Management; Medical Research & Clinical Studies; Product Outcome Evaluation); End-User (Government Organizations & Third-Party Administrators; Hospitals & Medical Practices; Private Payers; Pharmaceutical, Biotechnology & Medical Device Companies; Research Centers; Others); Geography (North America; Europe; Asia-Pacific; South America; Middle East and Africa) – Industry Trends and Forecast to 2026Market Analysis: Global Cancer Registry Software MarketGlobal cancer registry software market is expected to rise to an estimated value of USD 107.41 million by 2026, registering a healthy CAGR in the forecast period of 2019-2026.
This rise in market value can be attributed to the presence of various mandates and regulations for the adoption of electronic health record systems.Market Definition: Global Cancer Registry Software MarketCancer registry software is defined as a management system designed for exhibiting greater management services in cancer registry.
These software are capable of providing services required for better delivery of health care to patients such as collection, patient follow-up, abstraction of data, case finding and various other tools.
This information is stored in a secured central data center to provide access to users at any point of time.Get More Insight About the Global Cancer Registry Software Market, Request Sample @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-cancer-registry-software-market Market DriversSurging levels of patients suffering from cancer is expected to propel the growth of the marketPresence of various favorable initiatives by government organizations to reduce the incidences of cancer along with high adoption rate for this software from these organizations will boost the growth of the marketIncreasing utilization of this software to survey the post-marketing impact of pharmaceuticals and therapeutics also acts as a market driverFocus on improvement of health care facilities and quality along with reduction in the costs for provision of health care will augment the market growth in the forecast periodMarket RestraintsChances of theft of confidential data amid high prevalence of cyber-attacks is expected to hinder the growth of the marketLack of preference from a number of healthcare facilities to utilize advanced software solutions is expected to restrict this market growthKnow More About this Report @ https://www.databridgemarketresearch.com/reports/global-cancer-registry-software-market Segmentation: Global Cancer Registry Software MarketBy SoftwareCross-DisciplinarySpecificBy TypeStandaloneIntegratedBy Deployment ModelOn-PremiseCloud-BasedBy Database TypeCommercialPublicBy FunctionalityCancer Reporting to Meet State & Federal RegulationsPatient Care ManagementMedical Research & Clinical StudiesProduct Outcome EvaluationBy End-UserGovernment Organizations & Third-Party AdministratorsHospitals & Medical PracticesPrivate PayersPharmaceutical, Biotechnology & Medical Device CompaniesResearch CentersOthersBy GeographyNorth AmericaU.S.CanadaMexicoEuropeGermanyItalyU.K.FranceSpainNetherlandsBelgiumSwitzerlandTurkeyRussiaRest of EuropeAsia-PacificJapanChinaIndiaSouth KoreaAustraliaSingaporeMalaysiaThailandIndonesiaPhilippinesRest of Asia-PacificSouth AmericaBrazilRest of South AmericaMiddle East and AfricaSouth AfricaRest of Middle East and AfricaKey Developments in the Market:In April 2018, F. Hoffmann-La Roche Ltd announced that they had completed the acquisition of Flatiron Health.
This acquisition is projected to enhance the levels of progress of both organizations as they aim to enhance the personalization of healthcare services for cancer patientsIn October 2017, F. Hoffmann-La Roche Ltd announced the availability of “NAVIFY Tumor Board” solution designed for supporting the decision making process for patients suffering from cancer and reviewing their cases for tumor boards and multiple-disciplinary meetings.
The solution will primarily be available for U.S., U.K., Germany, Spain, Sweden and Switzerland regions and can help the way these meetings are carried outCompetitive Analysis:Global cancer registry software market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market.
Cancer Registry Software Market Report presents the conceptual study and strategic analysis which provides market scope, applications, a topographical presence that drive the Cancer Registry Software market.
Cancer Registry Software Market Global Industry report provides the latest market statistics, industry growth, size, share, trends, as well as driving factors.
The detailed overview of the market segments, product description, Cancer Registry Software applications is presented in this report.
Presence of various mandates and regulations for the adoption of electronic health record systems, increased focus on research and development proficiencies in regards to medical devices and on the adoption of advanced healthcare technologies, growing prevalence of cancer and rising expenditure on the healthcare infrastructure development especially in the developing economies are the major factors attributable to the growth of cancer registry software market.
Request Sample of Cancer Registry Software Market Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-cancer-registry-software-market Healthcare Infrastructure growth Installed base and New Technology PenetrationThe cancer registry software market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for digital health technologies market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the cancer registry software market.
This study also analyzes the market status, future trends, revenue generation, market share, growth rate, opportunities and challenges, sales volume, market drivers, market restraints, risks, and entry barriers.
